Disparity between matrix metalloproteinase-9 and tissue inhibitors of matrix metalloproteinase-1 correlated with the severity and adverse prognosis in patients with heart failure and systolic dysfunction

被引：0
|
作者：
Morishita, T. [1 ]
Mitsuke, Y. [1 ]
Nakano, A. [1 ]
Uzui, H. [1 ]
Geshi, T. [1 ]
Amaya, N. [1 ]
Sarazawa, K. [1 ]
Sato, T. [1 ]
Ishida, K. [1 ]
Lee, J. D. [1 ]
机构：
[1] Univ Fukui Hosp, Fukui, Japan
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：288 / 288
页数：1
相关论文
共 50 条
  • [1] Matrix Metalloproteinase-9/Tissue Inhibitor of Matrix Metalloproteinase-1 Ratio is Associated with the Severity and Major Adverse Cardiovascular Event in Patients with Systolic Heart Failure
    Morishita, Tetsuji
    Mitsuke, Yasuhiko
    Nakano, Akira
    Uzui, Hiroyasu
    Geshi, Toru
    Amaya, Naoki
    Sarazawa, Katsuhiko
    Sato, Takehiko
    Ishida, Kentaro
    Fukuoka, Yoshitomo
    Ikeda, Hiroyuki
    Murakami, Kiwamu
    Lee, Jong-Dae
    [J]. CIRCULATION, 2011, 124 (21)
  • [2] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [3] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in congestive heart failure - Reply
    Fonarow, Gregg C.
    Horwich, Tamara B.
    Eshaghian, Shervin
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01)
  • [4] MATRIX METALLOPROTEINASE-9 IS ASOCIATED WITH THE SEVERITY AND MAJOR ADVERSE CARDIOVASCULAR EVENT IN PATIENTS WITH SYSTOLIC HEART FAILURE
    Morishita, Tetsuji
    Uzui, Hiroyasu
    Arakawa, Kenichiro
    Amaya, Naoki
    Kaseno, Kenichi
    Ishida, Kentaro
    Sato, Takehiko
    Fukuoka, Yoshitomo
    Ikeda, Hiroyuki
    Ikeda, Etsuko
    Fujii, Ako
    Koike, Machiko
    Sato, Yusuke
    Hisazaki, Kaori
    Yamaguchi, Junya
    Lee, Jong-Dae
    Tada, Hiroshi
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A796 - A796
  • [5] Modulation of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in sepsis
    Maitra, Subir R.
    Jacob, Asha
    Zhou, Mian
    Wang, Ping
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 3 (03): : 180 - 185
  • [6] Matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 in multiple sclerosis
    Boz, Cavit
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 618 - 618
  • [7] Circulating matrix metalloproteinase-2 but not matrix metalloproteinase-3, matrix metalloproteinase-9, or tissue inhibitor of metalloproteinase-1 predicts outcome in patients with congestive heart failure
    George, J
    Patal, S
    Wexler, D
    Roth, A
    Sheps, D
    Keren, G
    [J]. AMERICAN HEART JOURNAL, 2005, 150 (03) : 484 - 487
  • [8] Circulating Matrix Metalloproteinase-9 in Chronic Heart Failure Patients Correlated With the Severity of Heart Failure and Outcome
    Morishita, Tetsuji
    Mitsuke, Yasuhiko
    Nakano, Akira
    Uzui, Hiroyasu
    Yamazaki, Taketoshi
    Geshi, Toru
    Sato, Takehiko
    Lee, Jong-Dae
    [J]. JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S157 - S157
  • [9] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in perinatal asphyxia
    Sunagawa, Shinpei
    Ichiyama, Takashi
    Honda, Rie
    Fukunaga, Shinnosuke
    Maeba, Shinji
    Furukawa, Susumu
    [J]. BRAIN & DEVELOPMENT, 2009, 31 (08): : 588 - 593
  • [10] Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in multiple sclerosis
    Gerlach, Raquel F.
    Tanus-Santos, Jose E.
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2006, 108 (06) : 617 - 618
12345